Emerson Invests in Fluxa

Emerson (NYSE: EMR), a technology and industrial software company, today announced it has made an equity investment in Fluxa, whose Process & Knowledge Management (PKMTM) software seamlessly manages product and process specifications throughout the drug development lifecycle. The investment will build on Emerson’s leading life sciences capabilities and help Fluxa expand its technology development and commercial pipeline to deliver solutions to the market.